Company intelligence / Profile preview

Impleo Medical

St. Paul, Minnesota, United Statesventureradar.com ↗

Ownership: Private
Employees: ~2
Development stage: Phase 2

Overview

Impleo Medical has developed a minimally invasive injection device for GERD. The product has completed a pilot study and entered pivotal clinical trials aiming for FDA approval. The device has also been used in over 100,000 patients for non-GERD indications.[4] No published pivotal results yet.

Therapeutic areas: Gastroenterology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Impleo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impleo Medical.

Explore the full profile